Table 2 The clinical characteristics of AML patients undergoing allo-HSCT.
Variables | Categories | N (%) |
|---|---|---|
Recipient age | < 35 years | 360 (48.5) |
> 35 years | 382 (51.5) | |
Recipient sex | Female | 429 (57.8) |
Male | 313 (42.2) | |
Donor sex | Female | 426 (57.4) |
Male | 316 (42.6) | |
Disease status | CRІ | 557 (75.1) |
CRП | 143 (19.2) | |
CRIII | 42 (5.7) | |
Sex matching (recipient-donor) | Male‒Male | 246 (33.2) |
Female‒Female | 133 (17.9) | |
Male‒Female | 180 (24.3) | |
Female‒Male | 183 (24.6) | |
ABO missmatching | Matched | 432 (58.3) |
Minor | 131 (17.6) | |
Major | 179 (24) | |
Donor type | Sibling | 652 (87.9) |
Unrelated | 37 (5.0) | |
Other relative | 53 (7.1) | |
aGVHD | No | 552 (74.4) |
Yes | 190 (25.6) | |
CD3 | < 284 | 371 (50.0) |
> 284 | 371 (50.0) | |
CD34 | < 5.1 | 378 (50.9) |
> 5.1 | 364 (49.1) |
